Townsend & Associates
MRK icon

Townsend & Associates’s Merck MRK Stock Holding History

Townsend & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.08M Buy
7,368
+54
+0.7% +$7.46K 0.09% 65
2026
Q2 		$910K Hold
7,314
– – 0.08% 70
2026
Q1 		$826K Hold
7,314
– – 0.07% 70
2025
Q4 		$812K Hold
7,314
– – 0.07% 70
2025
Q3 		$620K Hold
7,314
– – 0.06% 76
2025
Q2 		$620K Sell
7,314
-1
-0% -$79 0.06% 73
2025
Q1 		$569K Sell
7,315
-519
-7% -$48.5K 0.06% 74
2024
Q4 		$754K Sell
7,834
-98
-1% -$10.1K 0.08% 71
2024
Q3 		$844K Hold
7,932
– – 0.09% 69
2024
Q2 		$994K Hold
7,932
– – 0.11% 61
2024
Q1 		$1.01M Sell
7,932
-1
-0% -$123 0.12% 62
2023
Q4 		$943K Sell
7,933
-1,197
-13% -$124K 0.12% 63
2023
Q3 		$939K Sell
9,130
-23,553
-72% -$2.54M 0.2% 62
2023
Q2 		$3.51M Sell
32,683
-2,300
-7% -$261K 0.9% 40
2023
Q1 		$4.04M Sell
34,983
-14,249
-29% -$1.54M 1.62% 18
2022
Q4 		$5.39M Sell
49,232
-1,425
-3% -$146K 2.67% 9
2022
Q3 		$5.14M Buy
50,657
+1,647
+3% +$147K 2.38% 4
2022
Q2 		$4.62M Buy
49,010
+23,998
+96% +$2.13M 2.14% 4
2022
Q1 		$2.19M Buy
25,012
+2,278
+10% +$180K 1.01% 31
2021
Q4 		$1.85M Buy
22,734
+419
+2% +$33.4K 1.01% 40
2021
Q3 		$1.78M Buy
22,315
+6,340
+40% +$482K 0.88% 38
2021
Q2 		$1.24M Sell
15,975
-178
-1% -$13.2K 0.72% 54
2021
Q1 		$1.19M Buy
+16,153
New +$1.19M 0.77% 56
2018
Q4 		– Sell
-409
Closed -$28K – 118
2018
Q3 		$28K Buy
409
+3
+0.7% +$191 0.03% 109
2018
Q2 		$23K Buy
406
+5
+1% +$282 0.03% 111
2018
Q1 		$21K Buy
401
+3
+0.8% +$162 0.02% 113
2017
Q4 		$21K Buy
+398
New +$22.1K 0.02% 141

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Smead Capital Management
Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Townsend & Associates's MRK Position: Q3 2026 in Review

Townsend & Associates increased its Merck (MRK) stake by 0.74% in Q3 2026, buying an estimated $7.46K and bringing the position to 7,368 shares worth $1.08M. The position accounts for 0.09% of the portfolio, ranked #65.

Townsend & Associates first reported a position in MRK in Q4 2017 and has held it in 27 quarters since. The position peaked at $5.39M in Q4 2022. 1,788 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Townsend & Associates held 7,368 shares of Merck worth $1.08M as of Q3 2026.
  • Townsend & Associates bought 54 Merck shares in Q3 2026, an estimated $7.46K.
  • Merck made up 0.09% of Townsend & Associates's portfolio in Q3 2026, its #65 holding.
  • Townsend & Associates first reported a position in Merck in Q4 2017 and has held it in 27 quarters since.
  • Townsend & Associates's Merck position peaked at $5.39M in Q4 2022.
  • 1,788 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Townsend & Associates's 13F filing for Q3 2026, filed 23 Oct 2026.